Dysglycemia

Condition: Dysglycemia  |  Category: Metabolic Health  |  Reviewed by: Brian Lamkin, DO

What Is Dysglycemia?

Dysglycemia refers to any abnormality of blood glucose regulation that deviates from optimal metabolic function. This includes not only frank hyperglycemia and diabetes but also postprandial glucose spikes that return to normal before a fasting measurement is taken, reactive hypoglycemia after carbohydrate intake, glucose variability throughout the day, and the pre-diabetes glucose range that is actively damaging vascular and neurological tissue before any diagnosis is made.

A patient can have postprandial glucose spikes to 160-200 mg/dL with a completely normal fasting glucose and HbA1c of 5.3%, and be told their blood sugar is fine, while advanced glycation end-products (AGEs) accumulate in vascular walls and nervous tissue from the repetitive glycemic excursions that are never measured. Standard metabolic screening is structurally blind to the most clinically significant forms of blood sugar dysfunction.

Why It Matters

Common Symptoms

Root Causes: A Functional Medicine Perspective

Dysglycemia arises from the interaction of insulin resistance, pancreatic beta cell dysfunction, counter-regulatory hormone abnormalities, and dietary patterns. The primary driver in most cases is insulin resistance producing compensatory hyperinsulinemia that drives postprandial glucose control at the cost of subsequent reactive hypoglycemia. Cortisol elevation from chronic stress, sleep deprivation, or HPA axis dysregulation drives hepatic glucose output and blunts peripheral glucose uptake, producing the dawn phenomenon and glucose variability that persists even when dietary carbohydrate intake is reduced.

Gut microbiome composition influences postprandial glucose responses through mechanisms that explain why individuals respond dramatically differently to identical foods. Continuous glucose monitoring research has demonstrated that the same meal can produce a 30 mg/dL postprandial spike in one person and a 120 mg/dL spike in another, driven by differences in gut microbiome composition, gastric emptying rate, and insulin secretion kinetics. This individual variability is why personalized CGM-guided dietary advice produces superior outcomes to generic low-glycemic dietary recommendations.

Conventional vs Functional Medicine Approach

Key Labs to Evaluate

A complete dysglycemia evaluation requires markers that capture insulin dynamics and postprandial patterns that fasting glucose entirely misses.

How to Interpret These Labs Together

Common Patterns Seen in Patients

• The patient with afternoon crashes and carbohydrate cravings told their blood sugar is fine: fasting glucose of 88 mg/dL, HbA1c of 5.3%, fasting insulin of 16 uIU/mL; CGM reveals postprandial spikes to 172 mg/dL followed by drops to 62 mg/dL after lunch daily; 15 years of AGE accumulation and cardiovascular risk are underway while every standard marker looks normal
• The anxious patient whose anxiety is metabolic rather than psychological: anxiety attacks reliably occurring 2-3 hours after carbohydrate-heavy meals; cortisol and adrenaline counter-regulatory surges from reactive hypoglycemia producing sympathetic activation, palpitations, and anxiety that has been treated with SSRIs for years without addressing the glucose driver
• The morning glucose puzzle: fasting glucose of 108-118 mg/dL on repeated testing despite low-carbohydrate diet and normal postprandial glucose; elevated AM cortisol driving hepatic gluconeogenesis overnight; addressing the dawn phenomenon through cortisol optimization and timing of meals normalizes morning glucose without further dietary restriction
• The patient whose HbA1c rose without any dietary change: HbA1c from 5.4% to 6.1% over 18 months with no change in diet; continuous stress from a major life event elevated cortisol-driven hepatic glucose output and impaired peripheral glucose disposal; the glucose rise is a stress response masquerading as dietary failure

Treatment and Optimization Strategy

Dysglycemia treatment must target the specific mechanism present in that patient. Hyperinsulinemia-driven reactive hypoglycemia requires dietary carbohydrate reduction and insulin sensitization. Cortisol-driven hepatic glucose excess requires HPA axis optimization. Postprandial hyperglycemia from impaired beta cell kinetics requires food sequencing, post-meal activity, and GLP-1 support. Generic dietary advice fails because the same carbohydrate reduction that resolves one mechanism has minimal effect on another.

What Most Doctors Miss

• Fasting glucose below 100 mg/dL is interpreted as metabolic clearance: patients are told their blood sugar is fine based on fasting glucose alone while experiencing daily postprandial spikes to 160-180 mg/dL that accumulate AGE burden and vascular damage over years; neither the patient nor the physician knows this is happening because it is never measured
• Reactive hypoglycemia is attributed to anxiety: the sympathetic surge from hypoglycemic counter-regulation produces anxiety, palpitations, and irritability that are indistinguishable from anxiety disorder on clinical history alone; without postprandial glucose testing or CGM, the metabolic cause is never found and the patient is treated with anxiolytics rather than insulin-sensitizing intervention
• The cortisol-glucose connection is not investigated: morning glucose of 105-115 mg/dL is attributed to dietary carbohydrate excess in a patient who eats low-carbohydrate: the dawn phenomenon from cortisol-driven hepatic gluconeogenesis is the actual mechanism, but cortisol is never measured in metabolic evaluation
• Postprandial glucose testing and CGM are not used in non-diabetic patients: the tools that reveal the actual glucose pattern are reserved for patients who already have diabetes; by design, the evaluation system cannot detect the problem until it has progressed to frank disease

When to Seek Medical Care

Seek evaluation for dysglycemia if you experience afternoon energy crashes, mid-morning or mid-afternoon carbohydrate cravings, shakiness or anxiety between meals, brain fog after eating, waking at 2-4am, progressive weight gain despite appropriate caloric intake, or difficulty losing weight despite reasonable dietary efforts. These symptoms are metabolic until proven otherwise and deserve evaluation beyond fasting glucose.

Seek prompt evaluation if fasting glucose exceeds 110 mg/dL on repeated testing, if triglycerides exceed 200 mg/dL on a fasting lipid panel, or if HbA1c exceeds 5.6%: all of these indicate significant dysglycemia requiring active intervention rather than annual monitoring.

Recommended Testing

Frequently Asked Questions

How The Lamkin Clinic Approaches Dysglycemia

Dysglycemia evaluation at The Lamkin Clinic begins with fasting insulin, HOMA-IR, and C-peptide alongside standard glucose and HbA1c. For patients with glucose variability symptoms, a CGM trial is initiated before any dietary recommendations are made; individual glucose responses to food vary dramatically, and personalized dietary guidance based on actual CGM data produces superior outcomes to generic low-glycemic dietary advice. Treatment addresses the specific mechanism identified in that patient.

Related Conditions

Related Symptoms